Cargando…
Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics
BACKGROUND: Prognostic models based on individual patient characteristics can improve treatment decisions and outcome in the future. In many (radiomic) studies, small size and heterogeneity of datasets is a challenge that often limits performance and potential clinical applicability of these models....
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546238/ https://www.ncbi.nlm.nih.gov/pubmed/31158263 http://dx.doi.org/10.1371/journal.pone.0217536 |
_version_ | 1783423514162757632 |
---|---|
author | van Timmeren, Janna E. Carvalho, Sara Leijenaar, Ralph T. H. Troost, Esther G. C. van Elmpt, Wouter de Ruysscher, Dirk Muratet, Jean-Pierre Denis, Fabrice Schimek-Jasch, Tanja Nestle, Ursula Jochems, Arthur Woodruff, Henry C. Oberije, Cary Lambin, Philippe |
author_facet | van Timmeren, Janna E. Carvalho, Sara Leijenaar, Ralph T. H. Troost, Esther G. C. van Elmpt, Wouter de Ruysscher, Dirk Muratet, Jean-Pierre Denis, Fabrice Schimek-Jasch, Tanja Nestle, Ursula Jochems, Arthur Woodruff, Henry C. Oberije, Cary Lambin, Philippe |
author_sort | van Timmeren, Janna E. |
collection | PubMed |
description | BACKGROUND: Prognostic models based on individual patient characteristics can improve treatment decisions and outcome in the future. In many (radiomic) studies, small size and heterogeneity of datasets is a challenge that often limits performance and potential clinical applicability of these models. The current study is example of a retrospective multi-centric study with challenges and caveats. To highlight common issues and emphasize potential pitfalls, we aimed for an extensive analysis of these multi-center pre-treatment datasets, with an additional (18)F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) scan acquired during treatment. METHODS: The dataset consisted of 138 stage II-IV non-small cell lung cancer (NSCLC) patients from four different cohorts acquired from three different institutes. The differences between the cohorts were compared in terms of clinical characteristics and using the so-called ‘cohort differences model’ approach. Moreover, the potential prognostic performances for overall survival of radiomic features extracted from CT or FDG-PET, or relative or absolute differences between the scans at the two time points, were assessed using the LASSO regression method. Furthermore, the performances of five different classifiers were evaluated for all image sets. RESULTS: The individual cohorts substantially differed in terms of patient characteristics. Moreover, the cohort differences model indicated statistically significant differences between the cohorts. Neither LASSO nor any of the tested classifiers resulted in a clinical relevant prognostic model that could be validated on the available datasets. CONCLUSION: The results imply that the study might have been influenced by a limited sample size, heterogeneous patient characteristics, and inconsistent imaging parameters. No prognostic performance of FDG-PET or CT based radiomics models can be reported. This study highlights the necessity of extensive evaluations of cohorts and of validation datasets, especially in retrospective multi-centric datasets. |
format | Online Article Text |
id | pubmed-6546238 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-65462382019-06-17 Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics van Timmeren, Janna E. Carvalho, Sara Leijenaar, Ralph T. H. Troost, Esther G. C. van Elmpt, Wouter de Ruysscher, Dirk Muratet, Jean-Pierre Denis, Fabrice Schimek-Jasch, Tanja Nestle, Ursula Jochems, Arthur Woodruff, Henry C. Oberije, Cary Lambin, Philippe PLoS One Research Article BACKGROUND: Prognostic models based on individual patient characteristics can improve treatment decisions and outcome in the future. In many (radiomic) studies, small size and heterogeneity of datasets is a challenge that often limits performance and potential clinical applicability of these models. The current study is example of a retrospective multi-centric study with challenges and caveats. To highlight common issues and emphasize potential pitfalls, we aimed for an extensive analysis of these multi-center pre-treatment datasets, with an additional (18)F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) scan acquired during treatment. METHODS: The dataset consisted of 138 stage II-IV non-small cell lung cancer (NSCLC) patients from four different cohorts acquired from three different institutes. The differences between the cohorts were compared in terms of clinical characteristics and using the so-called ‘cohort differences model’ approach. Moreover, the potential prognostic performances for overall survival of radiomic features extracted from CT or FDG-PET, or relative or absolute differences between the scans at the two time points, were assessed using the LASSO regression method. Furthermore, the performances of five different classifiers were evaluated for all image sets. RESULTS: The individual cohorts substantially differed in terms of patient characteristics. Moreover, the cohort differences model indicated statistically significant differences between the cohorts. Neither LASSO nor any of the tested classifiers resulted in a clinical relevant prognostic model that could be validated on the available datasets. CONCLUSION: The results imply that the study might have been influenced by a limited sample size, heterogeneous patient characteristics, and inconsistent imaging parameters. No prognostic performance of FDG-PET or CT based radiomics models can be reported. This study highlights the necessity of extensive evaluations of cohorts and of validation datasets, especially in retrospective multi-centric datasets. Public Library of Science 2019-06-03 /pmc/articles/PMC6546238/ /pubmed/31158263 http://dx.doi.org/10.1371/journal.pone.0217536 Text en © 2019 van Timmeren et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article van Timmeren, Janna E. Carvalho, Sara Leijenaar, Ralph T. H. Troost, Esther G. C. van Elmpt, Wouter de Ruysscher, Dirk Muratet, Jean-Pierre Denis, Fabrice Schimek-Jasch, Tanja Nestle, Ursula Jochems, Arthur Woodruff, Henry C. Oberije, Cary Lambin, Philippe Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics |
title | Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics |
title_full | Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics |
title_fullStr | Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics |
title_full_unstemmed | Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics |
title_short | Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics |
title_sort | challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for nsclc patients using fdg-pet/ct radiomics |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546238/ https://www.ncbi.nlm.nih.gov/pubmed/31158263 http://dx.doi.org/10.1371/journal.pone.0217536 |
work_keys_str_mv | AT vantimmerenjannae challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics AT carvalhosara challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics AT leijenaarralphth challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics AT troostesthergc challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics AT vanelmptwouter challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics AT deruysscherdirk challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics AT muratetjeanpierre challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics AT denisfabrice challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics AT schimekjaschtanja challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics AT nestleursula challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics AT jochemsarthur challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics AT woodruffhenryc challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics AT oberijecary challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics AT lambinphilippe challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics |